| Project/Area Number |
07671440
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Kurume University |
|---|
Principal Investigator |
OGATA Yutaka Kurume University School of Medicine, Assistant Professor, 医学部, 講師 (20177124)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
INUTUKA Kiyohisa Kurume University School of Medicine, Assistant, 医学部, 助手 (10258395)
赤木 由人 久留米大学, 医学部, 助手 (90192880)
|
|---|
| Project Period (FY) |
1995 – 1996
|
| Project Status |
Completed (Fiscal Year 1996)
|
| Budget Amount *help |
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1996: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1995: ¥1,100,000 (Direct Cost: ¥1,100,000)
|
|---|
| Keywords | Colorectal Cancer / Liver Metastasis / Orthotopic Inoculated Colon Cancer / Matrix Metalloproteinase 9 / Matrix Metalloproteinase 3 / Urokinese Type Plasminogen Activator / Tissue INhibitor of Metalloproteinase 1 / Matrix Metalloprcteinase9 / Matrix Metalloprcteinase3 / プラスミノーゲンアフチベータ-(uPA) / Matrix Metalloprote / Tissue Inhibitor of Matrixmetalloproteinases 1 / Matrix Metalloproteinase 3 |
|---|
| Research Abstract |
Our previous biochemical studies showed that plasmin can activate proMMP-3, and MMP-3 can activate proMMP-9 readily. Toclarify significance of MMP-9, MMP-3, u-PA and TIMP-1 expression in colorectal cancer tissues we investigated the expression of MMP-9, MMP-3, TIMP-1, and u-PA in human colorectal cancer and orthtopically inoculated colon cancer of nude mice.
Immunohistochemistry and in situ hybridization demostrated that MMP-9 expressed by the tumor cells might play an important role in tumor development and progression, in particular in hematogenous metastasis in colorectal cancer, and that the balance between MMP-9 and TIMP-1 prodution in the tumor cells was important for liver metastasis from colon cancer. MMP-3 was observed in monocyte-macrophages and fibroblasis mainly at the tumor invasive front but not in the tumor cells. U-PA was noted mainly in the tumor cells, but the extent was variable. Both MMP-3 and u-PA tended to be co-expressed with MMP-9 at the tumor invasive front. In addition, both the incidence of MMP-3 and u-PA expression in tumor tissues in the cases with liver metastasis was significantly higher than in the cases without liver metastasis.
We conclude that MM-3 expresed by momocyte-macrophages and u-PA expressed by tumor cells may act as direct or indirect actiator for proMMP-9.
|
